Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 266

Related Citations for PubMed (Select 23169502)

1.

Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy: a national comprehensive cancer network analysis.

Khrizman P, Niland JC, ter Veer A, Milne D, Bullard Dunn K, Carson WE 3rd, Engstrom PF, Shibata S, Skibber JM, Weiser MR, Schrag D, Benson AB 3rd.

J Clin Oncol. 2013 Jan 1;31(1):30-8. doi: 10.1200/JCO.2011.40.3188. Epub 2012 Nov 19.

2.

[Practical neoadjuvant and adjuvant therapies for rectal cancer. How many patients are actually recruited in multimodality therapy concepts? An analysis of the Tumour Centre Schwerin].

Sauer J, Sobolewski K, Dommisch K.

Zentralbl Chir. 2009 Sep;134(5):450-4. doi: 10.1055/s-0028-1098930. Epub 2009 Sep 15. German.

PMID:
19757345
3.

[Local recurrence and survival rate after rectal cancer operations and multimodal therapy].

Thomschke D, Kyau-Ummen B, Halbfass HJ.

Chirurg. 2002 Mar;73(3):245-54. German.

PMID:
11963499
4.

Extensive surgery after high-dose preoperative chemoradiotherapy for locally advanced recurrent rectal cancer.

Rödel C, Grabenbauer GG, Matzel KE, Schick C, Fietkau R, Papadopoulos T, Martus P, Hohenberger W, Sauer R.

Dis Colon Rectum. 2000 Mar;43(3):312-9.

PMID:
10733111
5.

Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision.

Govindarajan A, Reidy D, Weiser MR, Paty PB, Temple LK, Guillem JG, Saltz LB, Wong WD, Nash GM.

Ann Surg Oncol. 2011 Dec;18(13):3666-72. doi: 10.1245/s10434-011-1788-y. Epub 2011 May 18.

PMID:
21590450
6.

An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.

Tulchinsky H, Shmueli E, Figer A, Klausner JM, Rabau M.

Ann Surg Oncol. 2008 Oct;15(10):2661-7. doi: 10.1245/s10434-008-9892-3. Epub 2008 Apr 4.

PMID:
18389322
7.

Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.

Arredondo J, Baixauli J, Beorlegui C, Arbea L, Rodríguez J, Sola JJ, Chopitea A, Hernández-Lizoáin JL.

Dis Colon Rectum. 2013 Apr;56(4):416-21. doi: 10.1097/DCR.0b013e318274d9c6.

PMID:
23478608
8.

Neoadjuvant radiotherapy use in locally advanced rectal cancer at NCCN member institutions.

Reyngold M, Niland J, ter Veer A, Milne D, Bekaii-Saab T, Cohen SJ, Lai L, Schrag D, Skibber JM, Small W Jr, Weiser M, Wilkinson N, Goodman KA.

J Natl Compr Canc Netw. 2014 Feb;12(2):235-43.

PMID:
24586085
9.

Abdominoperineal resection for rectal cancer at a specialty center.

Nissan A, Guillem JG, Paty PB, Douglas Wong W, Minsky B, Saltz L, Cohen AM.

Dis Colon Rectum. 2001 Jan;44(1):27-35; discussion 35-6.

PMID:
11805560
10.

Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.

Liersch T, Langer C, Ghadimi BM, Kulle B, Aust DE, Baretton GB, Schwabe W, Häusler P, Becker H, Jakob C.

J Clin Oncol. 2006 Sep 1;24(25):4062-8.

11.

Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.

Capirci C, Valentini V, Cionini L, De Paoli A, Rodel C, Glynne-Jones R, Coco C, Romano M, Mantello G, Palazzi S, Mattia FO, Friso ML, Genovesi D, Vidali C, Gambacorta MA, Buffoli A, Lupattelli M, Favretto MS, La Torre G.

Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):99-107. doi: 10.1016/j.ijrobp.2007.12.019. Epub 2008 Apr 11.

PMID:
18407433
12.

Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.

Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM).

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. Epub 2006 Jan 18.

PMID:
16414206
13.

Preoperative chemoradiotherapy and radical surgery for locally advanced distal rectal adenocarcinoma: pathologic findings and clinical implications.

Medich D, McGinty J, Parda D, Karlovits S, Davis C, Caushaj P, Lembersky B.

Dis Colon Rectum. 2001 Aug;44(8):1123-8.

PMID:
11535851
14.

A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.

Beddy D, Hyland JM, Winter DC, Lim C, White A, Moriarty M, Armstrong J, Fennelly D, Gibbons D, Sheahan K.

Ann Surg Oncol. 2008 Dec;15(12):3471-7. doi: 10.1245/s10434-008-0149-y. Epub 2008 Oct 10.

PMID:
18846402
15.

Evaluation of the efficacy of modified De Gramont and modified FOLFOX4 regimens for adjuvant therapy of locally advanced rectal cancer.

Koca D, Oztop I, Yavuzsen T, Ellidokuz H, Yilmaz U.

Asian Pac J Cancer Prev. 2011;12(12):3181-6.

16.

Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.

Wheeler JM, Dodds E, Warren BF, Cunningham C, George BD, Jones AC, Mortensen NJ.

Dis Colon Rectum. 2004 Dec;47(12):2025-31.

PMID:
15657650
17.

Is adjuvant chemotherapy really needed after curative surgery for rectal cancer patients who are node-negative after neoadjuvant chemoradiotherapy?

Kiran RP, Kirat HT, Burgess AN, Nisar PJ, Kalady MF, Lavery IC.

Ann Surg Oncol. 2012 Apr;19(4):1206-12. doi: 10.1245/s10434-011-2044-1. Epub 2011 Sep 21.

PMID:
21935748
19.

[Adjuvant and neoadjuvant therapy of rectal carcinoma. The current status].

Rödel C, Hohenberger W, Sauer R.

Strahlenther Onkol. 1998 Oct;174(10):497-504. Review. German.

PMID:
9810316
20.

Rectal cancer adjuvant chemotherapy: when is more useful?

Pasetto LM, Basso U, Sinigaglia G, Pucciarelli S, Friso ML, Rugge M, Toppan P, Agostini M, Monfardini S.

Anticancer Res. 2008 May-Jun;28(3B):1805-12.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk